EXPD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
EXPD is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a constructive technical setup, but the overall picture is mixed: analyst sentiment is mostly neutral-to-bearish, insiders are net sellers, Congress has recently sold, and the latest quarter showed revenue and net income declining year over year. I would not call it a clear buy today; the better call is to hold and wait for either a pullback into support or clearer fundamental improvement.
The price is 147.89, essentially unchanged at the close, with a slight regular-session decline of -0.60%. Technically, the stock is still in a bullish structure because SMA_5 > SMA_20 > SMA_200, which supports the longer-term uptrend. MACD histogram is positive at 0.19, but it is contracting, suggesting momentum is not accelerating. RSI_6 at 50.894 is neutral, so the stock is neither overbought nor oversold. The pivot is 148.49, very close to the current price, with nearby support at 145.847 and 144.213 and resistance at 151.133 and 152.767. Overall, the trend is mildly bullish but not strong enough to justify an aggressive entry after the recent flat-to-soft action.
["Bullish moving average alignment: SMA_5 > SMA_20 > SMA_200.", "MACD histogram remains positive, supporting the current uptrend.", "Options positioning is constructive with low put-call ratios.", "Earnings are scheduled soon, and consensus EPS estimate is 1.33, which could create a catalyst if results beat expectations.", "Gross margin improved meaningfully in the latest quarter, showing better operating efficiency."]
["Analyst sentiment is mixed to negative: one Sell, one Underweight, and two Hold/Neutral ratings.", "Recent price target cuts from Susquehanna and Truist signal reduced near-term confidence.", "Insiders are selling, with selling activity up 209.23% over the last month.", "Congress trading data shows 1 sale and 0 purchases in the last 90 days.", "Latest quarter revenue and net income both declined year over year.", "News flow is largely comparative and not showing a strong company-specific positive catalyst."]
In Q3 2025, Expeditors reported revenue of 2.8948 billion, down 3.51% year over year, and net income of 222.3 million, down 3.19% year over year. EPS increased to 1.64, up 0.61% year over year, and gross margin improved to 32.5%, up 9.50% year over year. This points to better margin efficiency, but top-line and bottom-line growth are still weak, so the latest quarter was mixed rather than strong.
Wall Street is mostly cautious. Susquehanna lowered its target to 142 and kept Neutral, JPMorgan raised its target to 135 but kept Underweight, Truist cut its target to 140 and stayed Hold, and Goldman raised its target to 129 but kept Sell. The recent trend is toward lower price targets and guarded commentary about ocean pressure, limited operating leverage, and AI-driven structural disruption risk. The pro case is that air trends and capital returns are improving; the con case is that ocean uncertainty, muted near-term leverage, and valuation skepticism continue to dominate.
